Dailypharm Live Search Close

Bringing 3rd gen monkeypox vaccine to Korea in discussion

By Lee, Jeong-Hwan | translator Alice Kang

22.06.07 12:00:01

°¡³ª´Ù¶ó 0
KDCA ¡°confirmed cases are increasing globally¡¦sees its inflow to Korea a possibility

Danish company Bavarian Nordic¡¯s ¡®Jynneos¡¯¡¦ the world¡¯s first to receive marketing authorization


The government announced on the 7th that it has started discussions on the quantity and schedule for bringing a ¡®3rd generation monkeypod vaccine¡¯ to Korea with its manufacturer.

The authorities decided to accelerate the introduction of this third-generation vaccine with proven efficacy as the number of confirmed cases of monkeypox continues to increase worldwide and the possibility of its inflow to Korea rises.

The Danish company Bavarian Nordic¡¯s ¡®Jynneos¡¯ is the only monkeypox vaccine that received marketing authorization in the world.

Jynneos is currently available for vaccination in the US and Canada after receiving FDA approval in 2019.

Jynneos i

Lee, Jeong-Hwan(junghwanss@dailypharm.com)
If you want to see the full article, please JOIN US (click)